Furthermore, cerebrospinal fluid (CSF) levels of SNAP25 (ref. 81) and synaptogamins82 have been assessed and found to be elevated in patients with Alzheimer’s disease or middle cognitive impairment, compared to controls. This evidence concerns the gene SNAP25 and Alzheimer disease.